Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05621863
Other study ID # 1788772
Secondary ID 13231928
Status Recruiting
Phase N/A
First received
Last updated
Start date April 1, 2023
Est. completion date August 31, 2026

Study information

Verified date May 2024
Source University of California, Davis
Contact Ellen L Bonnel, PhD
Phone 530-752-4184
Email ellen.bonnel@usda.gov
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to find a set of markers in the blood and/or urine that can be linked to consumption of specific fruits and vegetables. This will allow for better understanding of the link between diet and health-related outcomes. Furthermore, the results of this study will lead to the development of new methods to evaluate the nutritional status of individuals in both community and clinical settings. Food frequency questionnaires and diaries/recalls can be affected by intentional or unintentional misreporting, and thus can create errors in determining nutritional status. This study will lead to the development of an objective way to assess the consumption of specific fruits and vegetables by the general population.


Description:

The purpose of this research is to find a set of markers in the blood and/or urine that can be linked to consumption of specific fruits and vegetables. This will allow for better understanding of the link between diet and health-related outcomes. Furthermore, the results of this study will lead to the development of new methods to evaluate the nutritional status of individuals in both community and clinical settings. Food frequency questionnaires and diaries/recalls can be affected by intentional or unintentional misreporting, and thus can create errors in determining nutritional status. This study will lead to the development of an objective way to assess the consumption of specific fruits and vegetables by the general population. This study includes 3 aims to identify and then validate urine and plasma biomarkers associated with fruit and vegetable intake. Aim 1 will use a randomized crossover dietary intervention to determine the dose and time response of metabolites in plasma and urine associated with exposure to a mixture of MyPlate fruits and vegetables. Aim 2 will use a parallel design, controlled diet intervention to determine whether the biomarkers of fruit and vegetable intake determined in Aim 1 are predictors of consumption in the context of a defined dietary pattern. Aim 3 will be a cross-sectional validation arm that determines if the biomarkers of food intake developed in Aims 1 and 2 have predictive value reflecting recent and habitual consumption of these foods in a heterogeneous and diverse population.


Recruitment information / eligibility

Status Recruiting
Enrollment 280
Est. completion date August 31, 2026
Est. primary completion date April 30, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Body Mass Index (BMI) 18.5-39.9 kg/m^2 - Willingness to provide urine and have blood drawn Exclusion Criteria: - Pregnancy or lactation - Allergy or aversion to foods provided in test diet - History of gastrointestinal disorders including the following: 1. Ulcerative colitis or Crohn's disease 2. Celiac sprue 3. Hereditary non-polyposis colorectal cancer (HNPCC) 4. Familial adenomatous polyposis 5. Pancreatic disease 6. Liver disease - Previous gastrointestinal resection or bariatric surgery - Bleeding disorders that preclude blood draws - Recent hospital admissions (past 6 months) for myocardial infarction (MI), cerebrovascular accident (CVA), or congestive heart failure (CHF) - Cardiovascular disease (CVD) under physician guided therapy that is not medically stable - Cancer under radiation or chemotherapy treatment that is active or within 6 months of treatment - Weight change (± 5% in the last 3 months) - Regular alcohol intake of > 2 drinks/day (equivalent to 720 mL of beer, 240 mL of wine, or 90 mL of spirits), and unwilling to abstain during feeding periods - Use of tobacco and/or marijuana, hookahs, e-cigarettes, or vapes and not willing to abstain during feeding periods - Use of illicit drugs and not willing to abstain during feeding periods - BMI >40 kg/m^2 - Regular (daily to weekly) use of over-the-counter (OTC) weight-loss aids and unwilling or unable to stop taking these during feeding periods - Regular (daily to weekly) use of OTC anti-inflammatories and unwilling or unable to stop taking these during feeding periods - Unwilling to stop taking OTC dietary supplements that interfere with the test foods being studied including pills, chewables, liquids or powders for the following (may continue if vitamin supplement is prescribed by a medical doctor): 1. Protein supplements 2. Soy 3. Fiber 4. Flaxseed 5. Fish oil (including cod liver oil) 6. Probiotics 7. Carotenoids 8. Selenium 9. Other antioxidants 10. Other phytochemicals 11. Glucosamine 12. Chondroitin - Oral or IV antibiotic use in the past 6 months (could defer participation until 6 months post-completion of course of antibiotics) - Seated blood pressure >140/90 mmHg - Fasting clinical lab values outside of the following ranges: 1. Fasting Glucose: 54-125 mg/dL 2. Urea: 6-50 mg/dL 3. Creatinine: 0.4-1.3 mg/dL 4. Estimated Glomerular Filtration Rate (eGFR): >60 mL/min 5. Sodium: 133-146 mmol/L 6. Alanine Transaminase (ALT): 5-60 U/L 7. Aspartate Aminotransferase (AST): 5-40 U/L 8. Alkaline Phosphatase (ALP): 20-135 U/L 9. Total Bilirubin: 0.0-1.9 mg/dL 10. Total Protein: 5-9.0 g/dL 11. Albumin: 3.5-5.9 d/L 12. Low-density Lipoprotein (LDL) Cholesterol: <160 mg/dL 13. Triglycerides: <500 14. White Blood Cells: 3-10.5 Kl/µL 15. Hematocrit: 35-48 g/dL (women), 37.5-49 g/dL (men) - Current use of the following prescription medications: 1. Diuretics 2. Steroids (oral): daily oral any dose within 1 month of study (except for oral contraceptive pills) 3. Opiates: any use within 1 month of study 4. Hypolipidemic agents that affect GI or renal function (ie. fibrates) 5. Hypoglycemic medications other than metformin (ie. insulin, SGLT2 inhibitor, a-glucosidase inhibitor) 6. Psychiatric medications that affect metabolism/renal function (anti-psychotics, lithium) 7. Biologics/immune modulators (ie. rheumatoid arthritis, psoriasis, other rheumatologic/hematologic active disease) 8. Anti-coagulants (coumadin, heparin, Eliquis, etc.) 9. HIV/HAART medications (dyslipidemia inducing) - Inability to freely give informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Aim 1 Meal Challenge 1
A meal challenge will be provided that contains 1 serving of peaches and 2 servings of strawberries as a smoothie and 2 servings of tomatoes and 1 serving of carrot as a vegetable dish.
Aim 1 Meal Challenge 2
A meal challenge will be provided that contains 1 serving of banana and 2 servings of peaches as a smoothie and 1 serving of tomatoes and 2 servings of green beans as a vegetable dish.
Aim 1 Meal Challenge 3
A meal challenge will be provided that contains 2 serving of bananas and 1 serving of strawberries as a smoothie and 1 serving of green beans and 2 servings of carrots as a vegetable dish.
Aim 2 Typical American Diet
The diet will provide sufficient calories for weight maintenance and will contain refined grains and low amounts of fruits and vegetables, representative of the typical American diet. No bananas, strawberries, peaches, green beans, carrots, or tomatoes will be provided.
Aim 2 Typical American Diet Plus Test Foods
This diet will provide sufficient calories for weight maintenance and will contain refined grains and low amounts of fruits and vegetables, representative of the typical American diet. Bananas, strawberries, peaches, green beans, carrots, and tomatoes will be provided in amounts less than or equal to 1 serving per day each.
Aim 2 Dietary Guidelines for Americans Diet Plus Test Foods
This diet will provide sufficient calories for weight maintenance and will contain whole grains and high amounts of fruits and vegetables, representative of the Dietary Guidelines for Americans. Bananas, strawberries, peaches, green beans, carrots, and tomatoes will be provided in amounts greater than or equal to 1 serving per day each.

Locations

Country Name City State
United States USDA ARS Western Human Nutrition Research Center Davis California

Sponsors (2)

Lead Sponsor Collaborator
University of California, Davis USDA, Western Human Nutrition Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in urine metabolomics profile Urine metabolites will be measured by ultra-performance liquid chromatography mass spectrometry (UPLC-MS) before and after consumption of no, low, or high doses of study fruits and vegetables. Change will be assessed by the appearance of and change in levels of dietary-derived metabolites, which are candidate dietary biomarkers. Aim 1: day 3, 8, 13; overnight fasted and post prandial 0-2 hours, 2-4 hours, 4-6 hours, 6-8 hours, 8-24 hours. Aim 2: day 3, 9, 10; Aim 3: day 4.
Primary Change in plasma metabolomics profile Plasma metabolites will be measured by ultra-performance liquid chromatography mass spectrometry (UPLC-MS) before and after consumption of no, low, or high doses of study fruits and vegetables. Change will be assessed by the appearance of and change in levels of dietary-derived metabolites, which are candidate dietary biomarkers. Aim 1: day 3, 8, 13; overnight fasted and post prandial 1 hour, 2 hour, 3 hour, 4 hour, 5 hour, 6 hour, 7 hour, 8 hour, 24 hour. Aim 2: days 3, 9, 10. Aim 3: day 4.
Secondary Diet adherence Intake of test and non-test meals/foods will be monitored through weigh-backs by study personnel in Aim 1 and participant self report in Aim 2 to identify deviations in intake of fruits/vegetables of interest. Aim 1: day 3, 8, 13. Aim 2: day 3, 6, and 9.
Secondary Habitual consumption of fruits and vegetables 3-month General Nutrition Assessment Food Frequency Questionnaires (GNA FFQ) will be administered at site visit 1 for each aim. Day 1
Secondary Acute consumption of fruits and vegetables An Automated Self-Administered 24-Hour (ASA24) 3-day food record will be obtained over 2 weekdays and 1 weekend day during Aim 3. Days 1, 2, 3.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Recruiting NCT05548933 - Effects of Non-surgical Periodontal Therapy on Severe Periodontitis and Hyperlipidemia
Active, not recruiting NCT03926572 - Acute Decompensation of Pulmonary Hypertension N/A
Recruiting NCT05372159 - Vanderbilt Memory and Aging Project
Completed NCT03173586 - Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women N/A
Completed NCT04554628 - Early Prediction of Acute Kidney Injury Among Patients Admitted to Surgical ICU N/A
Terminated NCT03250312 - The Effects of OMT on the Expression Patterns of Immune Cell Biomarkers N/A
Recruiting NCT04666766 - Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers N/A
Completed NCT04573543 - The Role of Immune Semaphorins in NAFLD
Completed NCT03193671 - Evaluation and Implementation of New Biomarkers and Algorithms for Diagnosis of Ovarian Cysts/Tumors in the Pelvis N/A
Recruiting NCT06047132 - PREDICTIVE ABILITY OF A PANEL OF BIOMARKERS IN SALIVA IN HEALTHY AND PERIODONTALLY AFFECTED SUBJECTS
Completed NCT05361460 - Patients Experiences of Early Postoperative Cognition
Recruiting NCT05706194 - Early Neuroprognostication After OHCA
Recruiting NCT05138731 - Metabolomics Profiling of Coronary Heart Disease
Recruiting NCT06446895 - Biomarkers of Inflammation and Endothelial Dysfunction in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries
Not yet recruiting NCT04563000 - Impact of Vitamin C on Biomarkers of Neurologic Injury in Survivors of Cardiac Arrest Phase 2
Completed NCT05138692 - Biomarkers and Outcome 1 and 10-15 Years After Severe Traumatic Brain Injury
Completed NCT02247999 - Improving Cervical Cancer Screening Among HIV-Infected Women in India
Active, not recruiting NCT02732301 - Postoperative Gastrointestinal Dysfunction After Cardiac Surgery - Occurrence and Search for Biomarkers
Not yet recruiting NCT03269019 - Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia N/A